Skip to main content

April-June 2021

01_NPI_LUMAKRAS_VT_3 Day Notice

6-1-2021_Letter to Vermont Notifying & Reporting New Drugs

2021 – 42291-0439-30 – Launch

ABECMA_ 30 day Notice to Vermont_Bristol Myers Squibb

ADUHELM – VT 3-Day New Drug Notice

AvKare_NewLaunch_5.10.21

Baxter Cyclo Tab Vermont SPTR Noice

Drug Price Transparency – 3 Day Notice – VT_Albendazole

Drug Price Transparency – 30 Day Notice – VT_Albendazole

Drug Price Transparency – 30 Day Notice – VT_Ertapenem

Drug Price Transparency – 30 Day Notice – VT_Sapropterin Sachet

Drug_Price_Transparency- 3 Day Notice – VT Sapropterin_Sachet

Exelan_NewLaunch_76282.0677.30

Exelan_NewLaunch_76282.0678.30

Formoterol Fumarate MPI VT Notice – 06-24-21

GSK – SOTROVIMAB EUA

GSK 18 V.S.A 4637 JEMPERLI 30 DAY

GSK 18 V.S.A 4637 JEMPERLI

Isotretinoin 3 day notice VT

Lantheus Receives U.S. FDA Approval of PYLARIFY® (piflufolastat F 18) Injection, the First and Only Commercially Available PSMA PET Imaging Agent for Prostate Cancer

Letter to Office of Attorney General_New Drug Report Email – Etravirine

Lupin_Vermont State High Price Disclosure_5.28.2021_signed

MARGENZA_ VT New Drug Report 1Pack

MARGENZA_ VT New Drug Report 4Pack

Meitheal Pharmaceuticals Clofarabine Injection Vermont New Drug Submission_4.21.2021

Meitheal Pharmaceuticals Dactinomycin for Injection Vermont New Drug Report 5.20.2021

Meitheal Pharmaceuticals Vermont New Drug Notice – Generic Dactinomycin

New Document(9)

New Prescription Drug Notification SEVENFACT

New Product- 3 days notice Epic PharmaLLC-06.17.2021

New Product Launch Email Notice to VT

NNI VT 18 V.S.A

PLE IM – VT 30-Day New Drug Report

Rufinamide MPI VT Notice 06-03-21

RYBREVANT (amivantamab-vmjw) Receives FDA Approval

SKLSI XCopri 250 mg New Drug Notice VT

Submission SPTR Vermont BAXTER Cyclo Tab

TEMSIROLIMUS_ VT New Drug Report

Vermont PTR Submission Icatibant Launch

Vermont_3 Day Notice_Apellis

Vermont_30 Day New Drug Information Submission_Apellis

vermont-prescription-drug-reporting – 04-14-2021

VT 3 day new product letter -133 count

VT 3 day Notice of New Prescription Drug _(US_169518251_1)

VT 30 Day File – PONVORY

VT 30 Day File – RYBREVANT

VT 30 Day Notice Xcopri 250mg 05.7.2021

VT 30 day Report of New Prescription Drug

VT Act 193 New Drug Notice

VT Act 193 New Drug Notice_5.5.21

VT Act 193 New Drug Report

VT Act 193 New Drug Report_5.5.21

VT New Drug Initial Notice Report – INGREZZA 60 mg capsules

VT New Drug Pricing Report -ERYTHROMYCIN

VT New Drug Pricing Report -ISOTRETINOIN

VT New Drug Pricing Report -Tiopronin

VT New Drug Report – INGREZZA® 60 mg capsules

VT New Drug_Tolvaptan_30mg 1 tab_05_25_2021_signed

VT New Prod 3 Day – Isotretinoin Caps

VT New Prod 30 Day – Droxidopa Caps

VT New Prod 30 Day Report – Strides Pharma

VT Notice of New Drug Introduction – Formoterol Fumarate

VT Notice of New Drug Introduction – TIOPRONIN

VT Pentoxifylline WAC Increase 04.20.2021

VT Product Notification 3Day for Koselugo_Final 6.11

VT PTR Glipizide 20210518

VT_New_drug_notice_Arformoterol

VT_New_drug_notice_Rufinamide

VT_New_drug_report_Arformoterol

VT_New_drug_report_Rufinamide

VT_New_drug_report_Sirolimus_ 2mg

VT_New_drug_report_Sirolimus_Tabs_2mg

VT_Notice_of_New_Prescription_Drug_Myovant_Sciences_Inc._MYFEMBREE

Waylis Therapeutics State of Vermont Notice of New Drug Introduction Humatin 06112021

ZYNLONTA_ VT New Drug Notice

ZYNLONTA_ VT New Drug Report